The Board of Directors of the Center for Disease Dynamics, Economics & Policy is comprised of individuals representing the business community, public health organizations, former policymakers, as well as pre-eminent scholars. The board provides overall direction for the organization and meets twice annually. Members are eligible to serve for three three-year terms.
CDDEP is deeply committed to bringing to the board, in ever-greater numbers, leading figures from outside the United States as well as representatives of minority populations from North America.
Professional affiliations of board members are listed for identification purposes only.
Dean of the School of Public Policy
University of California, Riverside
Former Indian health secretary
Center for Disease Dynamics, Economics & Policy
Infection Control Programme & WHO Collaborating Centre on Patient Safety
The University of Geneva Hospitals and Faculty of Medicine
MRC/Wits Rural Public Health and Health Transitions Research Unit Head,
Health & Population Division, School of Public Health
University of the Witwatersrand
Johannesburg, South Africa
Ramanan Laxminarayan, Director
Ramanan Laxminarayan directs the Center for Disease Dynamics, Economics & Policy. He is also a visiting scholar and lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding of drug resistance as a problem of managing a shared global resource.
Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. In 2003-04, he served on the National Academy of Science/Institute of Medicine Committee on the Economics of Antimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC, NPR, Reuters, Science, Wall Street Journal, and National Journal.
Anil Deolalikar is Professor of Economics and Founding Dean of the School of Public Policy at the University of California, Riverside. He also serves as the Chair of the Board of Directors of the University of California Global Health Institute. He taught previously at the University of Washington, University of Pennsylvania, and Harvard University, and served as Lead Human Development Economist for the World Bank in India during 2002-03.
Deolalikar is a development economist who has published five books and nearly 75 articles on the economics of child nutrition, health, education, poverty, and social protection in developing countries.
He is co-editor of The Journal of Asian and African Studies and The Journal of Developing Societies. He is a Fellow of the American Association for the Advancement of Science. He was also a recipient of the Robert McNamara Fellowship for International Development awarded by the World Bank.
Deolalikar has served as consultant to a number of developing-country governments and international organizations, including the ADB, World Bank, UNDP and USAID, on a variety of research and policy projects.
He obtained his BA summa cum laude in economics from Harvard University, Diploma in Economics from Cambridge University, Ph.D. from Stanford University, and a Postdoctoral Fellowship in Economic Demography from Yale University.
Keshav Desiraju has recently retired from a career with the Indian Administrative Service and in 2013 was Secretary, Health & Family Welfare to the Government of India. He continues to remain engaged with issues in public health, particularly mental illness and mental health, primary health care and community health, and serves on the board of several non-profit organizations in the sector.
Didier Pittet, MD, MS, is Professor of Medicine, the Hospital Epidemiologist and Director of the Infection Control Programme and World Health Organization (WHO) Collaborating Centre on Patient Safety at the University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland. He holds Honorary Professorships at Imperial College London, UK, Hong Kong Polytechnic University School of Health Science, and the First Medical School of the Fu, Shanghai, China. Fellow, Royal Society of Medicine, Ireland. Honorary member, All-Russian Scientific Societies of Epidemiologists, Microbiologists and Parasitologists. Professor Pittet is Lead Adviser of the WHO “Saves Lives: Clean Your Hands campaign, active in more than 180 of the 194 UN member states.
Professor Pittet is the recipient of several national and international honours including a CBE (Commander of the British Empire) awarded by Her Majesty Queen Elisabeth II for services to the prevention of healthcare-associated infection in the UK (2007), the Society for Healthcare Epidemiology of America Lectureship for his contribution to infection control and healthcare epidemiology (2008), the European Society of Clinical Microbiology and Infectious Diseases’ Award for Excellence (2009), the American Society for Microbiology (ASM/ICAAC 2016) and the Robert Koch award (2017). The book “Clean Hands Save Lives” by the French writer Thierry Crouzet (Editions L’Âge d’Homme, 2014), published in 18 languages (2017), and the movie “Clean Hands” (AFTERMEDIA, 2016), describe Didier Pittet medical odyssey to promote patient safety worldwide.
Professor Pittet is co-author of more than 500 publications in peer-reviewed journals and 50 textbook chapters. He is the editor of the first textbook “Hand Hygiene – A Handbook for Medical Professionnals”- Pittet, Boyce, Allegranzi, Wiley-Blackwell, 2017). Professor Pittet serves on the editorial boards of several journals and is an editorial consultant of the Lancet. Professor Pittet has delivered a large number of plenary/opening lectures at all major meetings/congresses in the field of infectious diseases/infection control/patient safety. He is recognized as a fascinating and very engaging speaker. Professor Pittet current research interests include the epidemiology and prevention of healthcare-associated infections, methods for improving compliance with barrier precautions and hand hygiene practices, as well as innovative methods for improving the patient care and safety. He is also involved in research on the epidemiology of infectious diseases, and public and global health issues. The experience of his team in engaging nations and healthcare settings worldwide in a universal commitment to patient safety is unique.
Steve Tollman (BSc, MMed, MA, MPH, PhD) directs the MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt) and the Health and Population Division in the School of Public Health, University of the Witwatersrand. Internationally, he is guest professor in the Centre for Global Health Research, Umeå University, Sweden, and Principal Scientist for the INDEPTH Network (International Network for the Demographic Evaluation of Populations and Their Health).
In 1979 he graduated from Wits University with a BSc in Anatomy and Physiology. He continued studies at Wits obtaining his Bachelor of Medicine and Bachelor of Surgery degree in 1984 and Master of Medicine in 1999. Further studies took him to Oxford, UK and Harvard, USA culminating in a PhD in Public Health and Epidemiology from Umeå University, Sweden.
Steve was founding Board Chair of INDEPTH and is principal investigator for multi-centre research into Adult Health and Aging. He serves on several fellowship and grant review panels. Ongoing commission participation includes Migration and Health (UCL-Lancet); Global challenge of multimorbidity (Academy of Sciences, UK) and Continuing epidemiological transition in sub-Saharan Africa (National Academies of Science, USA).
Major research interests focus on adult health and aging, cardiometabolic disease and chronic care.